Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lennard

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemiaL Lennard, J S Lilleyman
Family Process|March 1, 1977
Architecture: effect of territory, boundary, and orientation on family functioningS H Lennard, H L Lennard
Haematologica|January 18, 2005
Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabineWendy Louise Osborne, Anne L Lennard
Rheumatology (Oxford, England)|October 21, 2003
Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprineG P R Clunie, L Lennard
Postgraduate Medical Journal|July 9, 1999
Management of non-Hodgkin's lymphomasP J Mounter, A L Lennard
Current Hematologic Malignancy Reports|September 14, 2011
Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategiesMichal K Sieniawski, Anne L Lennard
American Journal of Hospital Pharmacy|December 1, 1994
Overview of the New York State program for prescription drug benefitsE L Lennard, P E Feinberg
Journal of Clinical Pathology|May 1, 1984
Chronic lymphocytic leukaemia terminating in acute myelofibrosisA L Lennard, S J Proctor
Clinical Pharmacology and Therapeutics|September 1, 1986
Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrationsL Lennard, D Keen, J S Lilleyman
British Journal of Cancer|October 1, 1995
Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?L Lennard, J Welch, J S Lilleyman
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemiaL Lennard, J S Lilleyman
Family Process|March 1, 1977
Architecture: effect of territory, boundary, and orientation on family functioningS H Lennard, H L Lennard
Haematologica|January 18, 2005
Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabineWendy Louise Osborne, Anne L Lennard
Rheumatology (Oxford, England)|October 21, 2003
Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprineG P R Clunie, L Lennard
Postgraduate Medical Journal|July 9, 1999
Management of non-Hodgkin's lymphomasP J Mounter, A L Lennard
Current Hematologic Malignancy Reports|September 14, 2011
Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategiesMichal K Sieniawski, Anne L Lennard
American Journal of Hospital Pharmacy|December 1, 1994
Overview of the New York State program for prescription drug benefitsE L Lennard, P E Feinberg
Journal of Clinical Pathology|May 1, 1984
Chronic lymphocytic leukaemia terminating in acute myelofibrosisA L Lennard, S J Proctor
Clinical Pharmacology and Therapeutics|September 1, 1986
Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrationsL Lennard, D Keen, J S Lilleyman
British Journal of Cancer|October 1, 1995
Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?L Lennard, J Welch, J S Lilleyman
Pageof 9